Non-muscle-invasive bladder cancer is the most common type of bladder cancer. Many people are told it is “early-stage” or “highly treatable”, yet are not always prepared for the fact that care often continues over many years.
We are pleased to launch “Understanding Treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC)”, a new resource in the WBCPC Factsheet Series. This factsheet was developed to help patients and carers understand how NMIBC is treated over time and why regular follow-up is such an important part of care.
As 2025 ends, we take a moment to look back at what we achieved together. Our latest December newsletter brings together key moments from the past year and highlights the collective progress made across the global bladder cancer community.
Reflecting on a year of collective impact
Throughout 2025, the World Bladder Cancer Patient Coalition continued to grow its reach, strengthen patient advocacy, and expand international collaboration. As a result, this year alone,
The World Bladder Cancer Patient Coalition has launched the latest collaborative report Women Unseen: Tackling the Gender Care Gap in Bladder Cancer. The report examines the disparities women face across the bladder cancer pathway and outlines key actions to improve early diagnosis, clinical practice and overall care for women affected by bladder cancer.
The report brings together current evidence showing how women often experience delays in diagnosis, limited awareness of symptoms,
On November 26, 2025, the world marks the International Caregiver Day by appreciating the important contributions of carers around the world, especially those supporting people affected by bladder cancer.
Bladder cancer, the 9th most commonly diagnosed cancer globally, affects not only patients but also their families and friends. Carers, often close family members or friends, play an essential role in providing practical assistance and emotional support throughout the cancer journey.
Our Bladder Cancer Patient &
The World Bladder Cancer Patient Coalition is pleased to announce the launch of the Portuguese version of Factsheet 1: “What is Bladder Cancer?” developed in partnership with Instituto Oncoguia and CABEM Mais Vidas. This collaborative effort marks an important step in making clear, reliable information on bladder cancer more accessible to Portuguese-speaking patients, families and healthcare professionals.
This factsheet is designed as a decision-aid tool to support people who are newly diagnosed with bladder cancer.
